SG10201802650WA - Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives - Google Patents

Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

Info

Publication number: SG10201802650WA
Authority: SG; Singapore
Prior art keywords: glutarimide derivatives; methods; pharmaceutical composition; composition based; producing
Prior art date: 2013-04-12

Application number

SG10201802650WA

Inventor

Vladimir Evgenievich Nebolsin

Tatyana Alexandrovna Kromova

Original Assignee

Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-04-12

Filing date

2014-04-10

Publication date

2018-05-30

2013-04-12 Priority claimed from RU2013116826A external-priority patent/RU2562773C3/en

2014-04-10 Application filed by Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises filed Critical Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises

2018-05-30 Publication of SG10201802650WA publication Critical patent/SG10201802650WA/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

SG10201802650WA 2013-04-12 2014-04-10 Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives SG10201802650WA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
RU2013116826A RU2562773C3 (en)		2013-04-12	GLUTARIMIDE DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS OF THEIR PRODUCTION

Publications (1)

Publication Number	Publication Date
SG10201802650WA true SG10201802650WA (en)	2018-05-30

Family

ID=51689819

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
SG10201802650WA SG10201802650WA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
SG10201802648SA SG10201802648SA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
SG10201802647QA SG10201802647QA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
SG11201508394UA SG11201508394UA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
SG10201802648SA SG10201802648SA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
SG10201802647QA SG10201802647QA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
SG11201508394UA SG11201508394UA (en)	2013-04-12	2014-04-10	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

Country Status (15)

Country	Link
US (8)	US9815814B2 (en)
EP (3)	EP2985282A4 (en)
JP (4)	JP6529958B2 (en)
KR (3)	KR102254315B1 (en)
CN (4)	CN106061962B (en)
AU (5)	AU2014251442A1 (en)
BR (3)	BR122020010210B1 (en)
CA (1)	CA2909057C (en)
EA (4)	EA032951B1 (en)
IL (4)	IL266301B2 (en)
MX (4)	MX2020005736A (en)
SG (4)	SG10201802650WA (en)
UA (1)	UA121299C2 (en)
WO (1)	WO2014168522A1 (en)
ZA (3)	ZA201508278B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA121299C2 (en) *	2013-04-12	2020-05-12	Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез"	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
RU2552929C1 (en) *	2013-11-14	2015-06-10	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Pharmaceutical composition, containing derivatives of glutarimides, and their application for treatment of eosinophilic diseases
RU2628800C2 (en) *	2014-03-12	2017-08-22	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Amide compounds, methods for production, application as means for treatment and prevention of diseases caused by rna-containing viruses
CN106539792B (en) *	2016-11-07	2017-08-25	王晓旭	A kind of medicine for treating hyperlipemia
MD4788C1 (en) *	2017-09-07	2022-09-30	Ооо "Валента-Интеллект"	Use of a glutarimide derivative to treat diseases related to the aberrant activity of cytokines
JP2022506892A (en) *	2018-11-01	2022-01-17	アハンムネバイオサイエンシーズプライベートリミテッド	New imidazole compound, its synthesis method and its use
RU2712281C1 (en) *	2018-11-23	2020-01-28	Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс"	Use of a derivative glutarimide to overcome resistance to steroids and therapy of diseases associated with aberrant signaling of interferon gamma
CN115803026A (en) *	2020-06-26	2023-03-14	瓦伦塔有限责任公司	Use of glutarimide derivatives for the treatment of diseases associated with abnormal interleukin-6 activity
WO2023121519A1 (en) *	2021-12-23	2023-06-29	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Use of 1-[2-(1-methylimidazole-4-yl)-ethyl]perhydroazine-2,6-dione for treating covid-19
WO2023177329A1 (en) *	2022-03-18	2023-09-21	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Use of 1-(2-(1н-imidazole-4-yl)ethyl)piperidine-2,6-dione to treat cough caused by viral infections
WO2023191666A1 (en) *	2022-03-29	2023-10-05	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Crystalline form of 1-(2-(1н-imidazole-4-yl)ethyl)piperidine-2,6-dione and use thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3081308A (en) *	1959-12-29	1963-03-12	Searle & Co	5-carbocyclic-3-imidomethyloxazolidines and process
US3171839A (en) *	1961-05-18	1965-03-02	Searle & Co	4-alkyl-1-(cyclic imidoalkyl) piperidines
GB1033251A (en) *	1961-09-07	1966-06-22	Distillers Co Yeast Ltd	Glutarimide derivatives
US3963691A (en) *	1974-10-07	1976-06-15	Merck & Co., Inc.	Synthetic antigens of luteinizing hormone releasing hormone
US4261990A (en) *	1979-03-09	1981-04-14	Ciba-Geigy Corporation	N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics
JPS606686A (en)	1983-06-27	1985-01-14	Kissei Pharmaceut Co Ltd	Thiophene derivative and its preparation
JPS6066686A (en)	1983-09-19	1985-04-16	Toshiba Corp	Speed controller of line drive motor
SE8600261D0 (en) *	1986-01-21	1986-01-21	Lundblad Leif	INDOLOKINOXALINES WITH SUBSTITUTIONS IN 6-POSITION CONTAINING CYCLIC GROUPS
SU1836365A3 (en) *	1991-01-24	1993-08-23	Физиko-Xиmичeckий Иhctиtуt Иm.A.B.Бoгatckoгo;Hии@ Фapmakoлoгии Poccийckoй Amh	Method for obtaining n-(1-piperazinyl)butylglutarimidines
FR2737725B1 (en)	1995-08-08	1997-10-31	Valentonine	NOVEL ACYLATED DERIVATIVES OF MELATONIN AND MELATONINERGIC ANALOGS, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
RU2141483C1 (en)	1997-07-04	1999-11-20	Небольсин Владимир Евгеньевич	Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition
WO1999012910A1 (en) *	1997-09-11	1999-03-18	Nissan Chemical Industries, Ltd.	Pyrazole compounds and plant disease control agent
ITMI991578A1 (en) *	1999-07-15	2001-01-15	Recordati Ind Chimica E Farma	STARCHES AND CYCLIC IMIDES EQUIPPED WITH SELECTIVE ANTAGONIST ACTIVITY FOR THE ADRENERGIC RECEPTOR
US6413428B1 (en)	1999-09-16	2002-07-02	Berger Instruments, Inc.	Apparatus and method for preparative supercritical fluid chromatography
DE10002509A1 (en) *	2000-01-21	2001-07-26	Gruenenthal Gmbh	New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders
US7030150B2 (en) *	2001-05-11	2006-04-18	Trimeris, Inc.	Benzimidazole compounds and antiviral uses thereof
AU2003263393A1 (en) *	2002-09-04	2004-03-29	Glenmark Pharmaceuticals Limited	New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
RU2337908C2 (en)	2003-06-12	2008-11-10	Ново Нордиск А/С	Pyridinyl carbamates as hormone-sensitive lipase inhibitors
CN1260218C (en) *	2003-11-06	2006-06-21	天津药物研究院	PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof
WO2006040646A1 (en) *	2004-10-14	2006-04-20	Pfizer, Inc.	Benzimidazole or indole amides as inhibitors of pin1
BRPI0607062A2 (en) *	2005-02-28	2009-08-04	Japan Tobacco Inc	aminopyridine compound with syk inhibitory activity, pharmaceutical composition and therapeutic agent comprising the same
EP1741709A1 (en) *	2005-06-28	2007-01-10	Sanofi-Aventis Deutschland GmbH	Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
WO2007007054A1 (en)	2005-07-08	2007-01-18	Cancer Research Technology Limited	Phthalamides, succinimides and related compounds and their use as pharmaceuticals
US20120157387A1 (en) *	2006-11-28	2012-06-21	Apotex Technologies Inc.	Orally bioavailable d-gamma-glutamyl-d-tryptophan
US9453005B2 (en) *	2008-09-16	2016-09-27	The Trustees Of The University Of Pennsylvania	Inhibition of influenza M2 proton channel
EA025224B1 (en) *	2010-04-15	2016-12-30	Байота Сайентифик Менеджмент Пти Лтд.	USE OF 3-ETHOXY-6-{2-[1-(6-METHYL-PYRIDAZIN-3-YL)PIPERIDIN-4-YL]ETHOXY}BENZO[d]ISOXAZOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN THE TREATMENT OR ALLEVIATION OF SYMPTOMS OF ASTHMA
TW201217312A (en) *	2010-09-22	2012-05-01	Gruenenthal Gmbh	Substituted benzamide compounds
US20120157382A1 (en) *	2010-12-21	2012-06-21	Siegfried Krimmer	Pharmaceutical glp-1 compositions having an improved release profile
RU2665688C2 (en) *	2013-04-12	2018-09-04	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Dicarboxylic acid bisamide derivatives, their application, the pharmaceutical composition on their basis, methods for their production
UA121299C2 (en) *	2013-04-12	2020-05-12	Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез"	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
RU2552929C1 (en) *	2013-11-14	2015-06-10	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Pharmaceutical composition, containing derivatives of glutarimides, and their application for treatment of eosinophilic diseases

2014
- 2014-04-10 UA UAA201511008A patent/UA121299C2/en unknown
- 2014-04-10 SG SG10201802650WA patent/SG10201802650WA/en unknown
- 2014-04-10 JP JP2016507512A patent/JP6529958B2/en active Active
- 2014-04-10 EP EP14782170.6A patent/EP2985282A4/en not_active Withdrawn
- 2014-04-10 KR KR1020207016268A patent/KR102254315B1/en active IP Right Grant
- 2014-04-10 SG SG10201802648SA patent/SG10201802648SA/en unknown
- 2014-04-10 KR KR1020157032457A patent/KR102255929B1/en active IP Right Grant
- 2014-04-10 EP EP20178488.1A patent/EP3725785B1/en active Active
- 2014-04-10 MX MX2020005736A patent/MX2020005736A/en unknown
- 2014-04-10 CN CN201480032755.8A patent/CN106061962B/en not_active Expired - Fee Related
- 2014-04-10 MX MX2020005735A patent/MX2020005735A/en unknown
- 2014-04-10 BR BR122020010210-1A patent/BR122020010210B1/en not_active IP Right Cessation
- 2014-04-10 US US14/783,911 patent/US9815814B2/en active Active
- 2014-04-10 SG SG10201802647QA patent/SG10201802647QA/en unknown
- 2014-04-10 MX MX2015014336A patent/MX2015014336A/en unknown
- 2014-04-10 EP EP20178489.9A patent/EP3722290B1/en active Active
- 2014-04-10 EA EA201792072A patent/EA032951B1/en unknown
- 2014-04-10 BR BR122020010204-7A patent/BR122020010204B1/en active IP Right Grant
- 2014-04-10 MX MX2020005738A patent/MX2020005738A/en unknown
- 2014-04-10 BR BR112015025804-2A patent/BR112015025804B1/en not_active IP Right Cessation
- 2014-04-10 CN CN201910437243.4A patent/CN110172055B/en active Active
- 2014-04-10 IL IL266301A patent/IL266301B2/en unknown
- 2014-04-10 SG SG11201508394UA patent/SG11201508394UA/en unknown
- 2014-04-10 EA EA201591957A patent/EA031392B1/en unknown
- 2014-04-10 EA EA201792071A patent/EA033054B1/en unknown
- 2014-04-10 EA EA201792597A patent/EA032938B1/en not_active IP Right Cessation
- 2014-04-10 CN CN201910437241.5A patent/CN110229140B/en active Active
- 2014-04-10 AU AU2014251442A patent/AU2014251442A1/en not_active Abandoned
- 2014-04-10 CA CA2909057A patent/CA2909057C/en active Active
- 2014-04-10 CN CN201910437242.XA patent/CN110128406B/en active Active
- 2014-04-10 WO PCT/RU2014/000264 patent/WO2014168522A1/en active Application Filing
- 2014-04-10 KR KR1020207016274A patent/KR102296182B1/en active IP Right Grant
2015
- 2015-10-11 IL IL241998A patent/IL241998B/en active IP Right Grant
- 2015-11-10 ZA ZA2015/08278A patent/ZA201508278B/en unknown
2016
- 2016-05-10 ZA ZA2016/03109A patent/ZA201603109B/en unknown
- 2016-05-10 ZA ZA2016/03108A patent/ZA201603108B/en unknown
2017
- 2017-09-28 US US15/718,226 patent/US10155744B2/en active Active
- 2017-09-28 US US15/718,207 patent/US10155743B2/en active Active
- 2017-09-28 US US15/718,316 patent/US10155747B2/en active Active
- 2017-09-28 US US15/718,274 patent/US10196377B2/en active Active
- 2017-09-28 US US15/718,252 patent/US10155745B2/en active Active
- 2017-09-28 US US15/718,295 patent/US10155746B2/en active Active
2018
- 2018-09-27 AU AU2018236805A patent/AU2018236805C1/en not_active Ceased
- 2018-11-07 JP JP2018209575A patent/JP6843103B2/en active Active
- 2018-11-07 JP JP2018209574A patent/JP6620324B2/en active Active
- 2018-11-07 JP JP2018209573A patent/JP6627039B2/en active Active
- 2018-11-15 US US16/192,065 patent/US10377739B2/en active Active
2019
- 2019-04-29 IL IL266300A patent/IL266300B/en unknown
- 2019-04-29 IL IL266302A patent/IL266302B/en unknown
2020
- 2020-06-02 AU AU2020203632A patent/AU2020203632B2/en active Active
- 2020-06-02 AU AU2020203630A patent/AU2020203630B2/en active Active
- 2020-06-15 AU AU2020203968A patent/AU2020203968B2/en not_active Ceased

Also Published As

Publication number	Publication date
KR20160021092A (en)	2016-02-24
AU2020203632B2 (en)	2021-04-22
JP2019034964A (en)	2019-03-07
CA2909057C (en)	2022-03-22
KR102255929B1 (en)	2021-05-26
EA032938B1 (en)	2019-08-30
BR112015025804B1 (en)	2022-01-04
RU2562773C2 (en)	2015-09-10
IL266301B2 (en)	2023-03-01
EA201792597A3 (en)	2018-09-28
AU2020203632A1 (en)	2020-06-25
ZA201508278B (en)	2017-11-29
CA2909057A1 (en)	2014-10-16
AU2018236805B2 (en)	2020-04-09
EP3725785B1 (en)	2024-04-10
CN110229140A (en)	2019-09-13
KR20200069381A (en)	2020-06-16
RU2013116826A (en)	2014-10-20
US10155743B2 (en)	2018-12-18
MX2020005736A (en)	2021-06-14
JP6529958B2 (en)	2019-06-12
IL241998B (en)	2019-06-30
US10196377B2 (en)	2019-02-05
US20180016256A1 (en)	2018-01-18
US20190084961A1 (en)	2019-03-21
WO2014168522A4 (en)	2015-01-22
MX2020005738A (en)	2021-08-13
JP2019034966A (en)	2019-03-07
EA201792072A2 (en)	2018-04-30
AU2020203630B2 (en)	2021-04-22
EP2985282A1 (en)	2016-02-17
US10155746B2 (en)	2018-12-18
KR102296182B1 (en)	2021-09-02
EA032951B1 (en)	2019-08-30
EA031392B1 (en)	2018-12-28
IL266302B (en)	2021-09-30
MX2015014336A (en)	2016-06-07
EA033054B1 (en)	2019-08-30
EA201792597A2 (en)	2018-04-30
EA201591957A1 (en)	2016-02-29
AU2014251442A1 (en)	2015-12-03
EP3722290B1 (en)	2023-06-21
BR122020010204B1 (en)	2022-03-03
CN106061962A (en)	2016-10-26
US20180022728A1 (en)	2018-01-25
CN106061962B (en)	2019-09-06
SG11201508394UA (en)	2015-11-27
CN110172055A (en)	2019-08-27
CN110229140B (en)	2022-06-10
US10377739B2 (en)	2019-08-13
US20180016255A1 (en)	2018-01-18
AU2018236805A1 (en)	2018-10-18
IL266302A (en)	2019-06-30
IL266301B (en)	2022-11-01
US10155744B2 (en)	2018-12-18
AU2018236805C1 (en)	2020-11-05
JP6843103B2 (en)	2021-03-17
CN110128406B (en)	2021-08-27
BR122020010210B1 (en)	2022-09-20
CN110128406A (en)	2019-08-16
US10155745B2 (en)	2018-12-18
ZA201603109B (en)	2017-08-30
AU2020203630A1 (en)	2020-06-25
US9815814B2 (en)	2017-11-14
EA201792072A3 (en)	2018-09-28
JP2016516766A (en)	2016-06-09
EP3725785A1 (en)	2020-10-21
EA201792071A2 (en)	2018-04-30
BR112015025804A2 (en)	2017-07-25
EA201792071A3 (en)	2018-09-28
IL266300B (en)	2021-10-31
SG10201802647QA (en)	2018-05-30
ZA201603108B (en)	2017-08-30
AU2020203968B2 (en)	2021-04-22
IL266301A (en)	2019-06-30
US10155747B2 (en)	2018-12-18
KR102254315B1 (en)	2021-05-25
JP6627039B2 (en)	2020-01-08
US20160046598A1 (en)	2016-02-18
WO2014168522A9 (en)	2014-12-04
KR20200069380A (en)	2020-06-16
US20180016254A1 (en)	2018-01-18
MX2020005735A (en)	2021-06-21
US20180016253A1 (en)	2018-01-18
CN110172055B (en)	2021-10-29
EP3722290A1 (en)	2020-10-14
EP2985282A4 (en)	2017-02-22
SG10201802648SA (en)	2018-05-30
UA121299C2 (en)	2020-05-12
WO2014168522A1 (en)	2014-10-16
US20180016257A1 (en)	2018-01-18
JP6620324B2 (en)	2019-12-18
JP2019034965A (en)	2019-03-07
IL266300A (en)	2019-06-30
AU2020203968A1 (en)	2020-07-02

Publication	Publication Date	Title
IL266300B (en)	2021-10-31	Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
HK1215378A1 (en)	2016-08-26	Pharmaceutical composition, methods for treating and uses thereof
HK1215567A1 (en)	2016-09-02	Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof
HK1212980A1 (en)	2016-06-24	Pyridinone derivatives, preparation process and pharmaceutical use thereof
HK1221223A1 (en)	2017-05-26	Dicarboxylic acid bisamide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing dicarboxylic acid bisamide derivatives
HK1223360A1 (en)	2017-07-28	Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
EP3012256A4 (en)	2016-05-04	Benzimidazole-2-piperazine heterocyclic compound, pharmaceutical composition thereof, preparation method and use thereof
EP3037099A4 (en)	2017-04-19	Pharmaceutical composition, preparation method therefor and use thereof
EP3078659A4 (en)	2016-10-12	3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof
IL238851A0 (en)	2015-06-30	Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
HK1212968A1 (en)	2016-06-24	Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
HUP1300393A2 (en)	2014-12-29	Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same